Toronto, Canada-based BenchSci, a company providing AI-based solutions for drug discovery, has raised a $70 million Series D funding round.
The investment was led by Generation Investment Management, with participation from existing investors iNovia Capital, TCV, Golden Ventures and F-Prime Capital.
BenchSci has raised $170 million to date.